vs
Side-by-side financial comparison of PERRIGO Co plc (PRGO) and WATTS WATER TECHNOLOGIES INC (WTS). Click either name above to swap in a different company.
PERRIGO Co plc is the larger business by last-quarter revenue ($1.1B vs $625.1M, roughly 1.8× WATTS WATER TECHNOLOGIES INC). WATTS WATER TECHNOLOGIES INC runs the higher net margin — 13.4% vs -127.8%, a 141.2% gap on every dollar of revenue. On growth, WATTS WATER TECHNOLOGIES INC posted the faster year-over-year revenue change (15.7% vs -2.5%). PERRIGO Co plc produced more free cash flow last quarter ($148.6M vs $140.3M). Over the past eight quarters, WATTS WATER TECHNOLOGIES INC's revenue compounded faster (4.6% CAGR vs 1.3%).
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
AERCO International, Inc. is a manufacturer and supplier of commercial condensing boilers, high efficiency water heating equipment and energy recovery systems in the HVAC/plumbing industry across a variety of markets including education, lodging, government, office buildings, healthcare, industrial and multifamily housing. In 1949, AERCO introduced the industry's first semi-instantaneous, tankless steam-to-water water heater. In 1988, AERCO introduced the first condensing and fully modulating...
PRGO vs WTS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.1B | $625.1M |
| Net Profit | $-1.4B | $83.7M |
| Gross Margin | 32.6% | 49.5% |
| Operating Margin | -116.0% | 18.2% |
| Net Margin | -127.8% | 13.4% |
| Revenue YoY | -2.5% | 15.7% |
| Net Profit YoY | -3093.9% | 24.0% |
| EPS (diluted) | $-10.23 | $2.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.1B | $625.1M | ||
| Q3 25 | $1.0B | $611.7M | ||
| Q2 25 | $1.1B | $643.7M | ||
| Q1 25 | $1.0B | $558.0M | ||
| Q4 24 | $1.1B | $540.4M | ||
| Q3 24 | $1.1B | $543.6M | ||
| Q2 24 | $1.1B | $597.3M | ||
| Q1 24 | $1.1B | $570.9M |
| Q4 25 | $-1.4B | $83.7M | ||
| Q3 25 | $7.5M | $82.2M | ||
| Q2 25 | $-8.4M | $100.9M | ||
| Q1 25 | $-6.4M | $74.0M | ||
| Q4 24 | $-44.4M | $67.5M | ||
| Q3 24 | $-21.0M | $69.1M | ||
| Q2 24 | $-108.4M | $82.0M | ||
| Q1 24 | $2.0M | $72.6M |
| Q4 25 | 32.6% | 49.5% | ||
| Q3 25 | 36.1% | 48.8% | ||
| Q2 25 | 34.4% | 50.6% | ||
| Q1 25 | 37.6% | 48.8% | ||
| Q4 24 | 33.9% | 46.7% | ||
| Q3 24 | 37.2% | 47.3% | ||
| Q2 24 | 37.0% | 47.7% | ||
| Q1 24 | 33.1% | 46.9% |
| Q4 25 | -116.0% | 18.2% | ||
| Q3 25 | 7.0% | 18.2% | ||
| Q2 25 | 4.3% | 21.0% | ||
| Q1 25 | 4.5% | 15.7% | ||
| Q4 24 | 10.0% | 16.5% | ||
| Q3 24 | 7.4% | 17.1% | ||
| Q2 24 | -2.5% | 18.7% | ||
| Q1 24 | -5.1% | 16.9% |
| Q4 25 | -127.8% | 13.4% | ||
| Q3 25 | 0.7% | 13.4% | ||
| Q2 25 | -0.8% | 15.7% | ||
| Q1 25 | -0.6% | 13.3% | ||
| Q4 24 | -3.9% | 12.5% | ||
| Q3 24 | -1.9% | 12.7% | ||
| Q2 24 | -10.2% | 13.7% | ||
| Q1 24 | 0.2% | 12.7% |
| Q4 25 | $-10.23 | $2.50 | ||
| Q3 25 | $0.05 | $2.45 | ||
| Q2 25 | $-0.06 | $3.01 | ||
| Q1 25 | $-0.05 | $2.21 | ||
| Q4 24 | $-0.32 | $2.02 | ||
| Q3 24 | $-0.15 | $2.06 | ||
| Q2 24 | $-0.79 | $2.44 | ||
| Q1 24 | $0.01 | $2.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $405.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.9B | $2.0B |
| Total Assets | $8.5B | $2.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $405.5M | ||
| Q3 25 | $432.1M | $457.7M | ||
| Q2 25 | $454.2M | $369.3M | ||
| Q1 25 | $409.9M | $336.8M | ||
| Q4 24 | $558.8M | $386.9M | ||
| Q3 24 | $1.5B | $303.9M | ||
| Q2 24 | $542.8M | $279.4M | ||
| Q1 24 | $658.5M | $237.1M |
| Q4 25 | $2.9B | $2.0B | ||
| Q3 25 | $4.4B | $2.0B | ||
| Q2 25 | $4.5B | $1.9B | ||
| Q1 25 | $4.4B | $1.8B | ||
| Q4 24 | $4.3B | $1.7B | ||
| Q3 24 | $4.6B | $1.7B | ||
| Q2 24 | $4.5B | $1.6B | ||
| Q1 24 | $4.7B | $1.6B |
| Q4 25 | $8.5B | $2.9B | ||
| Q3 25 | $10.1B | $2.7B | ||
| Q2 25 | $10.1B | $2.6B | ||
| Q1 25 | $9.8B | $2.5B | ||
| Q4 24 | $9.6B | $2.4B | ||
| Q3 24 | $11.2B | $2.4B | ||
| Q2 24 | $10.4B | $2.4B | ||
| Q1 24 | $10.6B | $2.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $175.4M | $154.7M |
| Free Cash FlowOCF − Capex | $148.6M | $140.3M |
| FCF MarginFCF / Revenue | 13.4% | 22.4% |
| Capex IntensityCapex / Revenue | 2.4% | 2.3% |
| Cash ConversionOCF / Net Profit | — | 1.85× |
| TTM Free Cash FlowTrailing 4 quarters | $145.1M | $356.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $175.4M | $154.7M | ||
| Q3 25 | $51.7M | $122.4M | ||
| Q2 25 | $75.9M | $69.7M | ||
| Q1 25 | $-64.5M | $55.2M | ||
| Q4 24 | $312.6M | $139.5M | ||
| Q3 24 | $42.2M | $90.7M | ||
| Q2 24 | $9.5M | $85.3M | ||
| Q1 24 | $-1.4M | $45.6M |
| Q4 25 | $148.6M | $140.3M | ||
| Q3 25 | $29.8M | $110.9M | ||
| Q2 25 | $56.7M | $59.5M | ||
| Q1 25 | $-90.0M | $45.6M | ||
| Q4 24 | $274.9M | $127.5M | ||
| Q3 24 | $15.1M | $84.3M | ||
| Q2 24 | $-18.9M | $78.5M | ||
| Q1 24 | $-26.5M | $35.5M |
| Q4 25 | 13.4% | 22.4% | ||
| Q3 25 | 2.9% | 18.1% | ||
| Q2 25 | 5.4% | 9.2% | ||
| Q1 25 | -8.6% | 8.2% | ||
| Q4 24 | 24.2% | 23.6% | ||
| Q3 24 | 1.4% | 15.5% | ||
| Q2 24 | -1.8% | 13.1% | ||
| Q1 24 | -2.4% | 6.2% |
| Q4 25 | 2.4% | 2.3% | ||
| Q3 25 | 2.1% | 1.9% | ||
| Q2 25 | 1.8% | 1.6% | ||
| Q1 25 | 2.4% | 1.7% | ||
| Q4 24 | 3.3% | 2.2% | ||
| Q3 24 | 2.5% | 1.2% | ||
| Q2 24 | 2.7% | 1.1% | ||
| Q1 24 | 2.3% | 1.8% |
| Q4 25 | — | 1.85× | ||
| Q3 25 | 6.89× | 1.49× | ||
| Q2 25 | — | 0.69× | ||
| Q1 25 | — | 0.75× | ||
| Q4 24 | — | 2.07× | ||
| Q3 24 | — | 1.31× | ||
| Q2 24 | — | 1.04× | ||
| Q1 24 | -0.70× | 0.63× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
WTS
Segment breakdown not available.
